HKU Scholars Hub: Browsing DSpace

Browsing by Author Nyaw, SF

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 6 of 6

	Title	Author(s)	Issue Date
	169P Genomic landscape of NSCLC brain metastases and its potential association with TP53 and tumor mutation burden: A territory-wide program in Hong Kong Journal:ESMO Open	Kam, TY Wong, CHL Fong, JKS Lee, VHF Chiu, MKL Cheung, KM Nyaw, SF Lim, MY Kwan, CK Mok, STF Lee, AWM	20-Mar-2024
	175P Quality of life in patients with NSCLC brain metastases undergoing different local therapies in the era of precision oncology: A territory-wide study Journal:ESMO Open	Wong, CHL Kam, TY Fong, JKS Lee, VHF Chiu, MKL Cheung, KM Nyaw, SF Lim, MY Kwan, CK Mok, STF Lee, AWM	20-Mar-2024
	380MO A phase II trial of atezolizumab, bevacizumab, pemetrexed and carboplatin combination for metastatic EGFR-mutated NSCLC after TKI failure Proceeding/Conference:Annals of Oncology	Lam, TC Tsang, KC Choi, CW Lee, VHF Lam, KO Chiang, CL So, TH Chan, WLW Nyaw, SF Lim, F Lau, JO Chil, J Kong, FP Lee, WMA	2020
	51P Exploring the prognostic value of TP53 mutation in NSCLC in the era of precision oncology: A prospective real-world study Journal:ESMO Open	Chiu, MKL Wong, CHL Fong, JKS Ko, EY-L Lee, VHF Kam, TY Cheung, KM Nyaw, SF Kwan, CK Mok, STF Lee, AWM Lim, MY	1-Mar-2024
	Can Quantitative Measures of T790M Allelic Fraction Predict Survival Outcomes in Patients Receiving Osimertinib? Observations From an Early Access Programme Journal:Clinical Oncology	Chan, OSH Lee, VHF Nyaw, SF Kam, MTY Lee, KWC Lam, KC	2021
	Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure Journal:Lung Cancer	Lam, TC Tsang, KC Choi, HC Lee, VH Lam, KO Chiang, CL So, TH Chan, WW Nyaw, SF Lim, F Lau, JO Chik, J Kong, FM Lee, AW	2021

Showing results 1 to 6 of 6